perindopril has been researched along with Dementia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Souček, M | 1 |
| Beckett, N; Bulpitt, C; Fagard, R; Fletcher, A; Forette, F; Pereira, L; Peters, R; Thijs, L; Wang, JG | 1 |
| Beckett, N; Bulpitt, C; Burch, L; Clarke, R; Comsa, M; Fletcher, A; Forette, F; Ma, S; Peters, R; Poulter, R; Ritchie, C; Tuomilehto, J; Waldman, A; Walton, I | 1 |
| Anderson, C; Bousser, MG; Chalmers, J; Coskun, O; Dufouil, C; Godin, O; MacMahon, S; Mazoyer, B; Tzourio, C; Tzourio-Mazoyer, N | 1 |
| Beckett, N; Peters, R | 1 |
| Beckett, N; Bulpitt, C; Fletcher, A; Grimley-Evans, J; McCormack, T; Nunes, M; Peters, R; Pinto, E; Potter, J; Swift, C | 1 |
| Jackson, SH; Mukhtar, O | 1 |
| Anderson, C; Chalmers, J; Chapman, N; MacMahon, S; Neal, B; Tzourio, C; Woodward, M | 1 |
| Widimský, J | 1 |
| Cambien, F; Chalmers, J; Chapman, N; Colman, S; Harrap, SB; Leguennec, S; MacMahon, S; Neal, B; Ohkubo, T; Poirier, O; Raoux, S; Tzourio, C; Woodward, M | 1 |
| Hasegawa, Y | 1 |
| Anderson, C; Tzourio, C | 1 |
3 review(s) available for perindopril and Dementia
| Article | Year |
|---|---|
Hypertension, dementia, and antihypertensive treatment: implications for the very elderly.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cognition; Dementia; Female; Humans; Hypertension; Male; Perindopril; Propranolol; Risk Factors | 2009 |
The Hypertension in the Very Elderly Trial - latest data.
Topics: Aged, 80 and over; Antihypertensive Agents; Cognition Disorders; Delayed-Action Preparations; Dementia; Double-Blind Method; Drug Therapy, Combination; Fractures, Bone; Humans; Hypertension; Indapamide; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic | 2013 |
[PROGRESS].
Topics: Activities of Daily Living; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Dementia; Double-Blind Method; Humans; Hypertension; Peptidyl-Dipeptidase A; Perindopril; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Risk; Secondary Prevention; Stroke | 2006 |
6 trial(s) available for perindopril and Dementia
| Article | Year |
|---|---|
Increased pulse pressure linked to dementia: further results from the Hypertension in the Very Elderly Trial - HYVET.
Topics: Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cognition; Dementia; Double-Blind Method; Female; Humans; Hypertension; Indapamide; Male; Perindopril; Proportional Hazards Models; Pulsatile Flow; Regression Analysis; Risk Factors; Treatment Outcome | 2013 |
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial.
Topics: Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cognition; Dementia; Double-Blind Method; Female; Geriatric Assessment; Humans; Hypertension; Incidence; Indapamide; Longitudinal Studies; Male; Mental Status Schedule; Neuropsychological Tests; Perindopril | 2008 |
Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Brain; Cerebrovascular Disorders; Cognition Disorders; Dementia; Disease Progression; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Perindopril; Predictive Value of Tests; Recurrence; Stroke | 2009 |
Association of depression with subsequent mortality, cardiovascular morbidity and incident dementia in people aged 80 and over and suffering from hypertension. Data from the Hypertension in the Very Elderly Trial (HYVET).
Topics: Aged, 80 and over; Antihypertensive Agents; Cardiovascular Diseases; Dementia; Depression; Female; Geriatric Assessment; Humans; Hypertension; Indapamide; Longitudinal Studies; Male; Perindopril; Risk Factors; Stroke | 2010 |
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cerebrovascular Disorders; Cognition; Cognition Disorders; Dementia; Diuretics; Double-Blind Method; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Risk; Treatment Outcome | 2003 |
Blood pressure reduction and risk of dementia in patients with stroke: rationale of the dementia assessment in PROGRESS (Perindopril Protection Against Recurrent Stroke Study). PROGRESS Management Committee.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Dementia; Female; Humans; Male; Middle Aged; Perindopril; Risk Factors; Stroke | 2000 |
3 other study(ies) available for perindopril and Dementia
| Article | Year |
|---|---|
In the prevention of dementia, the focus should be on early and consistent treatment of hypertension.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Dementia; Drug Combinations; Humans; Hypertension; Middle Aged; Perindopril | 2023 |
[Management of dementia and cognitive functions in patients after cerebrovascular stroke: new results from the PROGRESS study].
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cognition Disorders; Dementia; Humans; Hypertension; Indapamide; Middle Aged; Perindopril; Randomized Controlled Trials as Topic; Stroke | 2003 |
The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cognition Disorders; Dementia; Female; Genotype; Humans; Hypertension; Male; Middle Aged; Mutagenesis, Insertional; Peptidyl-Dipeptidase A; Perindopril; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Risk Factors; Sequence Deletion; Statistics as Topic; Stroke; Survival Analysis; Time Factors; Treatment Outcome; Vascular Diseases | 2003 |